Skip to main content
See every side of every news story
Published • loading... • Updated

Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib. Last week, the former senator from Nebraska Ben Sasse announced that his Stage 4 pancreatic cancer had developed resistance to a cutting edge treatment. Cancer specialists were … Source

3 Articles

El DiarioEl Diario
Reposted by
eldiariodechihuahua.mxeldiariodechihuahua.mx
Center

Last week, Nebraska’s former senator Ben Sasse announced that his stage 4 pancreatic cancer had developed resistance to state-of-the-art treatment. Cancer specialists were not surprised: almost all patients with pancreatic cancer who take this medication, called Daraxonrasib, end up developing resistance, said Dr. Andrew Aguirre, a pancreatic cancer specialist at the Dana-Farber Cancer Institute in Boston. The drug, approved in August, caused a …

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

eldiariodechihuahua.mx broke the news on Wednesday, September 30, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal